Correlation Between Viridian Therapeutics and Fidelity National

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Fidelity National at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Fidelity National into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Fidelity National Information, you can compare the effects of market volatilities on Viridian Therapeutics and Fidelity National and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Fidelity National. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Fidelity National.

Diversification Opportunities for Viridian Therapeutics and Fidelity National

0.37

Correlation Coefficient

Viridian Therapeutics  Fidelity National

Weak diversification

The 3 months correlation between Viridian and Fidelity is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Fidelity National Information in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity National and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Fidelity National. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity National has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Fidelity National go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Fidelity National

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the Fidelity National. In addition to that, Viridian Therapeutics is 1.2 times more volatile than Fidelity National Information. It trades about -0.01 of its total potential returns per unit of risk. Fidelity National Information is currently generating about 0.03 per unit of volatility. If you would invest  5,918  in Fidelity National Information on November 20, 2024 and sell it today you would earn a total of  1,068  from holding Fidelity National Information or generate 18.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.77%
Values	Daily Returns

Viridian Therapeutics  vs.  Fidelity National Information

Viridian Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Fidelity National

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fidelity National Information has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Viridian Therapeutics and Fidelity National

The main advantage of trading using opposite Viridian Therapeutics and Fidelity National positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Fidelity National can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity National will offset losses from the drop in Fidelity National's long position.

The idea behind Viridian Therapeutics and Fidelity National Information pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.